Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Thomas Berg

Showing results (531-540 of 633) with videos related to

Pageof 64
Sort By:
Journal of Hepatology|December 3, 2015
Evaluation of APRI and FIB-4 scoring systems for non-invasive assessment of hepatic fibrosis in chronic hepatitis B patientsW Ray Kim, Thomas Berg, Tarik Asselah, et al.
Plos One|June 7, 2018
Successful direct acting antiviral (DAA) treatment of HCV/HIV-coinfected patients before and after liver transplantationJulia M Grottenthaler, Christoph R Werner, Martina Steurer, et al.
Journal of Cancer Research and Clinical Oncology|April 15, 2021
Baseline Interleukin-6 and -8 predict response and survival in patients with advanced hepatocellular carcinoma treated with sorafenib monotherapy: an exploratory post hoc analysis of the SORAMIC trialOsman Öcal, Kerstin Schütte, Juozas Kupčinskas, et al.
Hepatology International|July 24, 2015
Extended treatment with pegylated interferon alfa/ribavirin in patients with genotype 2/3 chronic hepatitis C who do not achieve a rapid virological response: final analysis of the randomised N-CORE trialMitchell L Shiffman, Hugo Cheinquer, Christoph P Berg, et al.
JHEP Reports : Innovation in Hepatology|July 10, 2023
Cell-based BSEP trans-inhibition: A novel, non-invasive test for diagnosis of antibody-induced BSEP deficiencyJan Stindt, Carola Dröge, Elke Lainka, et al.
Ebiomedicine|August 13, 2021
Copy number variation and expression of exportin-4 associates with severity of fibrosis in metabolic associated fatty liver diseaseMayada Metwally, Ali Bayoumi, Anis Khan, et al.
Human Molecular Genetics|July 11, 2008
First evidence for an association of a functional variant in the microRNA-510 target site of the serotonin receptor-type 3E gene with diarrhea predominant irritable bowel syndromeJohannes Kapeller, Lesley A Houghton, Hubert Mönnikes, et al.
Journal of Hepatology|August 28, 2022
Long-term persistence of HCV resistance-associated substitutions after DAA treatment failureJulia Dietz, Beat Müllhaupt, Peter Buggisch, et al.
Alimentary Pharmacology & Therapeutics|June 8, 2020
A prospective, multicentre study in acute non-cirrhotic, non-malignant portal vein thrombosis: comparison of medical and interventional treatmentMartin Rössle, Dominik Bettinger, Jonel Trebicka, et al.
Gut|July 12, 2014
Entecavir treatment does not eliminate the risk of hepatocellular carcinoma in chronic hepatitis B: limited role for risk scores in CaucasiansPauline Arends, Milan J Sonneveld, Roeland Zoutendijk, et al.
Pageof 64

Showing results (531-540 of 633) with videos related to

Sort By:
Pageof 64
Journal of Hepatology|December 3, 2015
Evaluation of APRI and FIB-4 scoring systems for non-invasive assessment of hepatic fibrosis in chronic hepatitis B patientsW Ray Kim, Thomas Berg, Tarik Asselah, et al.
Plos One|June 7, 2018
Successful direct acting antiviral (DAA) treatment of HCV/HIV-coinfected patients before and after liver transplantationJulia M Grottenthaler, Christoph R Werner, Martina Steurer, et al.
Journal of Cancer Research and Clinical Oncology|April 15, 2021
Baseline Interleukin-6 and -8 predict response and survival in patients with advanced hepatocellular carcinoma treated with sorafenib monotherapy: an exploratory post hoc analysis of the SORAMIC trialOsman Öcal, Kerstin Schütte, Juozas Kupčinskas, et al.
Hepatology International|July 24, 2015
Extended treatment with pegylated interferon alfa/ribavirin in patients with genotype 2/3 chronic hepatitis C who do not achieve a rapid virological response: final analysis of the randomised N-CORE trialMitchell L Shiffman, Hugo Cheinquer, Christoph P Berg, et al.
JHEP Reports : Innovation in Hepatology|July 10, 2023
Cell-based BSEP trans-inhibition: A novel, non-invasive test for diagnosis of antibody-induced BSEP deficiencyJan Stindt, Carola Dröge, Elke Lainka, et al.
Ebiomedicine|August 13, 2021
Copy number variation and expression of exportin-4 associates with severity of fibrosis in metabolic associated fatty liver diseaseMayada Metwally, Ali Bayoumi, Anis Khan, et al.
Human Molecular Genetics|July 11, 2008
First evidence for an association of a functional variant in the microRNA-510 target site of the serotonin receptor-type 3E gene with diarrhea predominant irritable bowel syndromeJohannes Kapeller, Lesley A Houghton, Hubert Mönnikes, et al.
Journal of Hepatology|August 28, 2022
Long-term persistence of HCV resistance-associated substitutions after DAA treatment failureJulia Dietz, Beat Müllhaupt, Peter Buggisch, et al.
Alimentary Pharmacology & Therapeutics|June 8, 2020
A prospective, multicentre study in acute non-cirrhotic, non-malignant portal vein thrombosis: comparison of medical and interventional treatmentMartin Rössle, Dominik Bettinger, Jonel Trebicka, et al.
Gut|July 12, 2014
Entecavir treatment does not eliminate the risk of hepatocellular carcinoma in chronic hepatitis B: limited role for risk scores in CaucasiansPauline Arends, Milan J Sonneveld, Roeland Zoutendijk, et al.
Pageof 64